PDX BIOTECH

PDX BIOTECH

Makers of OraStripdx, the rapid point-of-care test for active periodontal disease in dogs.

Founded 2019

Vancouver, United States 3 employees Seed Health Care, Health and Wellness

OraStripdx is a growth-stage biotechnology company based in Louisville, Kentucky, specializing in the early detection of periodontal disease in dogs and cats. The company's flagship product is OraStripdx, a revolutionary rapid test that can detect active periodontal disease in dogs and cats in ten seconds, without the need for anesthesia or sedation. This represents a significant advancement in the industry, particularly given that periodontal disease is an invisible infection that causes needless suffering for millions of animals. In peer-reviewed studies, OraStripdx has been found to be significantly more effective than the visual awake exam in detecting active periodontal disease, marking a crucial breakthrough in the early diagnosis of this condition. Furthermore, the disease itself can also serve as a warning sign of more serious health issues such as diseases of the heart and kidneys, adding to the significance of OraStripdx's contribution to animal healthcare. The company has attracted seed round investment from ROC VENTURE GROUP in June 2023, signifying the market's belief in the potential of OraStripdx. With a focus on enhancing client compliance with veterinarian recommendations, the routine use of OraStripdx has been shown to significantly increase practice revenue and improve patient care. In conclusion, OraStripdx holds a unique and promising position within the healthcare industry, addressing a critical need in the early detection of periodontal disease in animals. The recent investment from ROC VENTURE GROUP underscores the confidence in the company's innovative approach and the potential impact it can have on the well-being of pets. Startup's innovative approach and strong focus on addressing a crucial pain point in the veterinary industry positions it as a compelling proposition for further venture capital interest and industry disruption.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed Round	Undisclosed	1	ROC VENTURE GROUP	21 Jun 2023

Funding Stage

Amount

Investors

Lead Investors

Date

Seed Round

Undisclosed

ROC VENTURE GROUP

21 Jun 2023

FAQ About PDX BIOTECH

Makers of OraStripdx, the rapid point-of-care test for active periodontal disease in dogs.

PDX BIOTECH was founded in 2019.

PDX BIOTECH is headquartered in Vancouver, United States.

PDX BIOTECH operates in Health Care and Health and Wellness. Its work centres on Veterinary diagnostics, Animal health, Periodontal disease and Rapid testing.

PDX BIOTECH has approximately 3 employees.

PDX BIOTECH has completed 1 funding round. The latest funding stage is Seed.

Top alternatives and competitors to PDX BIOTECH include HERINGS, NeuroCatch®, ZiO Health, Premier Medical Corporation Private Limited, Attomarker. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

PDX BIOTECH and HERINGS are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About PDX BIOTECH

Funding Rounds & Investors (1)

PDX BIOTECH Alternatives & Competitors

FAQ About PDX BIOTECH